PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
25-Mar-2024 CAS Announces 2024 Selections for Prestigious CAS Future Leaders™ Program CAS
22-Mar-2024 4SC AG provides results for financial year 2023 and outlook for 2024 4SC AG
22-Mar-2024 First patient in the UK is dosed in the OATD-01 Phase 2 KITE study in pulmonary sarcoidosis Molecure S.A.
22-Mar-2024 HUTCHMED Initiates Registration Stage of the ESLIM-02 Phase II/III Trial of Sovleplenib for Warm Antibody Autoimmune Hemolytic Anemia in China HUTCHMED
22-Mar-2024 CD Formulation Introduces Microneedle Patch Innovations for Enhanced Drug Delivery Efficiency CD Formulation
20-Mar-2024 New light-activated antimicrobial expands usage across Canada Ondine Biomedical Inc.
20-Mar-2024 Scintil Photonics Andrew Lloyd Associates
20-Mar-2024 CD Formulation Offers Accurate and Reliable Impurity Determination for Biopharmaceutical Studies CD Formulation
20-Mar-2024 Alfa Chemistry Adds to Its Lineup of Derivatization Reagents for High-Performance Liquid Chromatography (HPLC) Alfa Chemistry
18-Mar-2024 Essex Bio-Technology Posts Sound 2023 Annual Financial Results, Revenue Up 29.5%, Profit Up 22.1% Essex Bio-Technology Limited
18-Mar-2024 CryoLogyx Completes £500k Seed Funding Round Codon Communications
15-Mar-2024 Lundbeck’s potential first-in-class therapy for migraine prevention enters advanced clinical stage Lundbeck
15-Mar-2024 Syngene biologics manufacturing facility to be operational for US and European customers from mid-year Syngene
15-Mar-2024 SunWay Biotech and Gnosis by Lesaffre Form Alliance to Launch MenaQ7® Metabolic, featuring the ANKASCIN® 568-R ingredient SunWay Biotech
15-Mar-2024 Syngene biologics manufacturing facility to be operational for US and European customers from mid-year New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day Syngene International
14-Mar-2024 Bayer and Aignostics to collaborate on next generation precision oncology Bayer and Aignostics GmbH
14-Mar-2024 Mission Therapeutics raises £25.2 million to progress clinical candidates in the area of mitophagy Mission Therapeutics
14-Mar-2024 BioInnovation Institute welcomes innovative smartRNA project to Bio Studio program BioInnovation Institute
14-Mar-2024 Asgard Therapeutics announces €30 million Series A financing to advance its first-in-class in vivo cell reprogramming platform for immuno-oncology Asgard Therapeutics
14-Mar-2024 Anocca AB Licenses Gene Editing Technology from EmendoBio Inc. Anocca AB